Insulet Corporation (PODD) |
|
318.96 2.08 (0.66%)
|
03-31 16:00 |
|
Open: |
318.78 |
Pre. Close: |
316.88 |
|
High:
|
324.1797 |
Low:
|
318.31 |
|
Volume:
|
882,088 |
Market Cap:
|
22,181(M) |
|
|
|
Technical analysis |
as of: 2023-03-31 4:21:22 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 381.63 One year: 445.74 |
| Support: |
Support1: 291.09 Support2: 269.05 |
| Resistance: |
Resistance1: 326.73 Resistance2: 381.63 |
| Pivot: |
313.44  |
| Moving Average: |
MA(5): 314.99 MA(20): 306.41
MA(100): 297.22 MA(250): 261.83 |
| MACD: |
MACD(12,26): 6.3 Signal(9): 5.8 |
| Stochastic oscillator: |
%K(14,3): 78.7 %D(3): 77.4 |
| RSI: |
RSI(14): 60.6 |
| 52-week: |
High: 326.73 Low: 181 |
| Average Vol(K): |
3-Month: 841 (K) 10-Days: 624 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ PODD ] has closed below upper band by 23.3%. Bollinger Bands are 42.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
324.57 - 325.82 |
325.82 - 327.07 |
|
Low:
|
315 - 316.51 |
316.51 - 318.02 |
|
Close:
|
316.56 - 318.84 |
318.84 - 321.12 |
|
Company Description |
|
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. |
Headline News |
Sat, 01 Apr 2023
Here are the 20 best performing stocks of March — and the 20 worst - Morningstar
Fri, 31 Mar 2023
DexCom Inc. stock outperforms market on strong trading day - MarketWatch
Thu, 30 Mar 2023
Insulet to Announce First Quarter 2023 Financial Results on May 4 ... - Business Wire
Tue, 28 Mar 2023
Insulet (PODD) Benefits From Omnipod 5 Launch, Expansion - Nasdaq
Tue, 21 Mar 2023
Guru Fundamental Report for PODD - Nasdaq
Sun, 19 Mar 2023
Should You Invest in Insulet Corporation (PODD)? - Yahoo Finance
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
69 (M) |
| Shares Float |
69 (M) |
|
% Held by Insiders
|
0.4 (%) |
|
% Held by Institutions
|
104.6 (%) |
|
Shares Short
|
2,210 (K) |
|
Shares Short P.Month
|
2,140 (K) |
Stock Financials |
|
EPS
|
0.1 |
|
EPS Est Next Qtl
|
-0.11 |
|
EPS Est This Year
|
-0.51 |
|
EPS Est Next Year
|
-0.24 |
|
Book Value (p.s.)
|
9.14 |
|
Profit Margin (%)
|
1.3 |
|
Operating Margin (%)
|
5.1 |
|
Return on Assets (ttm)
|
1.9 |
|
Return on Equity (ttm)
|
3.6 |
|
Qtrly Rev. Growth
|
23.7 |
|
Gross Profit (p.s.)
|
10.82 |
|
Sales Per Share
|
17.85 |
|
EBITDA (p.s.)
|
1.8 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
43 (M) |
|
Levered Free Cash Flow
|
-42 (M) |
Stock Valuations |
|
PE Ratio
|
3189.59 |
|
PEG Ratio
|
25.3 |
|
Price to Book value
|
34.89 |
|
Price to Sales
|
17.86 |
|
Price to Cash Flow
|
517.56 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
